Some parents of sickle cell children seek govt. assistance 

Some parents of sickle cell children seek govt. assistance
Assistance
By Ijendu Iheaka
Aba (Abia), June 22, 2024 (NAN) Some parents of children with Sickle Cell Disease (SCD) have appealed to government to assist them, as cost of drugs and treatment have skyrocketed.
They made the appeal in separate interviews with the News Agency of Nigeria (NAN) on the sidelines of an event by Vicar Hope Foundation to commemorate 2024 World Sickle Cell Day in Aba, Abia on Saturday.
NAN reports that the global observance day is annually celebrated on June 19World Sickle Cell Day is an annual observance held on June 19 to raise awareness about sickle cell disease.
The theme for 2024 commemoration is “Hope Through Progress: Advancing Sickle Cell Care Globally.”
The parents, therefore, pleaded for urgent help to save their children’s lives, saying they cannot afford the cost of the medication and management of the disease.
One of the parents, Mrs Ngozi Ogbonna, said that a false laboratory test result  caused her to marry her husband who had AS gene like herself which produced four children, with two being SS.
She said that managing two children with the sickle cell gene had become  expensive, hence the need for government assistance.
Ogbonna said government should not leave the medical care of children with SCD to the parents of patients if they want such children to survive and be useful.
Another parent, Okechukwu Joseph, said  that his second daughter, a SCD patient, had been a source of huge expenses to the family.
He added that “my experience with the doctors is that they are not doing the best that is required, so they need more specialised training.
“At FMC Umuahia, my child was left to student doctors who were using her for experiments, hospitals should do better.
“And government should consider the lives of these poor children with SCD and save them by assisting in their healthcare, which cost has become unaffordable to many parents now,” he said.
Ogechi Onyekachi, whose twin boys are also living with the disorder, said it had not been easy caring for them, “especially in this season of high cost of drugs and treatment.”
She begged government to come to her aid and other poor families “because taking care of SCD children has become a herculean task.”
Dr Emeka Nwakamma, a Medical Consultant, earlier in his speech said SCD patients could prolong their lives by avoiding painful crisis and infections.
He counselled patients to drink plenty of water, avoid getting too hot or too cold, hard exercises and exposure to low oxygen levels to escape painful crisis.
He defined SCD as a group of blood disorders inherited from a person’s parents the same way people get the colour of their eyes, skin and hair.
He said “a person with SCD is born with it and it occurs when he/she inherits two abnormal copies of hemoglobin gene, one from each parent.
“The abnormal genes with sickle cell traits include hemoglobin SS, also called sickle cell anemia, the most severe form of the disease, hemoglobin SC; S-beta thalassemia; hemoglobin SD and SE.
“Sickle Cell Trait (SCT), also called carrier state occurs when only one abnormal copy of the Hemoglobin gene is inherited, such as Hemoglobin AS,” he said.
He explained that persons with AS genes do not usually have symptoms and signs of SCD, but could transmit the gene to their children, thereby propagating the disease condition.
Nwakamma said there is no single best treatment for all people with SCD, as  options are different for each person, depending on the symptoms.
He said that SCD treatments include blood transfusion, drinking much water, intravenous fluid therapy and medications to reduce pain, prompt malaria and other infections treatment.
The consultant said that for severe SCD, a medicine called hydroxyurea might be recommended to reduce painful crisis and hospital stays.
He  said that the recommended treatment modality in the horizon is Gene therapy, which, however, is not everywhere now. (NAN)(www.nannews.ng)
IEI /OJI/HA
===========
Edited by Maureen Ojinaka/Hadiza Mohammed-Aliyu

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *